What's new
| Date | Content |
|---|---|
| 01/12/2022 | Periodic safety update single assessment: Human rabies immunoglobulin : List of nationally authorised medicinal products - PSUSA/00001639/202204 |
| 01/12/2022 | Orphan designation: 1-(3-{4-[3,4-difluoro-2-(trifluoromethyl)phenyl]piperidine-1-carbonyl}-1H,4H,5H,6H,7H-pyrazolo[3,4- c]pyridin-6-yl)ethan-1-one (Tinlarebant) for the: Treatment of Stargardt's disease, 25/05/2018, Positive |